1. Home
  2. RVMDW vs MBINN Comparison

RVMDW vs MBINN Comparison

Compare RVMDW & MBINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMDW
  • MBINN
  • Stock Information
  • Founded
  • RVMDW 2014
  • MBINN N/A
  • Country
  • RVMDW United States
  • MBINN United States
  • Employees
  • RVMDW N/A
  • MBINN 618
  • Industry
  • RVMDW
  • MBINN Major Banks
  • Sector
  • RVMDW
  • MBINN Finance
  • Exchange
  • RVMDW Nasdaq
  • MBINN Nasdaq
  • Market Cap
  • RVMDW N/A
  • MBINN N/A
  • IPO Year
  • RVMDW N/A
  • MBINN N/A
  • Fundamental
  • Price
  • RVMDW $0.18
  • MBINN $21.75
  • Analyst Decision
  • RVMDW
  • MBINN
  • Analyst Count
  • RVMDW 0
  • MBINN 0
  • Target Price
  • RVMDW N/A
  • MBINN N/A
  • AVG Volume (30 Days)
  • RVMDW 15.6K
  • MBINN N/A
  • Earning Date
  • RVMDW 02-26-2025
  • MBINN N/A
  • Dividend Yield
  • RVMDW N/A
  • MBINN N/A
  • EPS Growth
  • RVMDW N/A
  • MBINN N/A
  • EPS
  • RVMDW N/A
  • MBINN N/A
  • Revenue
  • RVMDW $742,000.00
  • MBINN N/A
  • Revenue This Year
  • RVMDW N/A
  • MBINN N/A
  • Revenue Next Year
  • RVMDW N/A
  • MBINN N/A
  • P/E Ratio
  • RVMDW N/A
  • MBINN N/A
  • Revenue Growth
  • RVMDW N/A
  • MBINN N/A
  • 52 Week Low
  • RVMDW $0.10
  • MBINN N/A
  • 52 Week High
  • RVMDW $0.12
  • MBINN N/A
  • Technical
  • Relative Strength Index (RSI)
  • RVMDW N/A
  • MBINN 49.82
  • Support Level
  • RVMDW N/A
  • MBINN $21.50
  • Resistance Level
  • RVMDW N/A
  • MBINN $22.10
  • Average True Range (ATR)
  • RVMDW 0.00
  • MBINN 0.36
  • MACD
  • RVMDW 0.00
  • MBINN -0.03
  • Stochastic Oscillator
  • RVMDW 0.00
  • MBINN 33.33

About RVMDW Revolution Medicines Inc. Warrant

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About MBINN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and Banking segment that provides a wide range of financial products and services to consumers and businesses, including commercial and other consumer loan products.

Share on Social Networks: